Dr. Nickols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15128 Vose St
Van Nuys, CA 91405Phone+1 818-421-5077
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2010 - 2014
University of California (Irvine)Internship, Internal Medicine, 2009 - 2010
David Geffen School of Medicine at UCLAClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer Start of enrollment: 2018 Jul 01
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Start of enrollment: 2021 Mar 17
Publications & Presentations
PubMed
- Corrigendum to "Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Resul...Wesley R Armstrong, Amar U Kishan, Kiara M Booker, Tristan R Grogan, David Elashoff
European Urology. 2025-01-01 - 1 citationsTestosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Rando...Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, John Nikitas, David Joseph
European Urology. 2025-01-01 - 1 citationsMolecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.Adam B Weiner, Raag Agrawal, Nicholas K Wang, Ida Sonni, Eric V Li
European Urology. 2024-12-01
Press Mentions
Three UCLA/VA Researchers to Be Honored by Secretary of Veterans AffairsMay 4th, 2023- ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
